Paroxetine Hydrochloride Prolonged Release Tablets 37.5 mg

About Paroxetine Hydrochloride Prolonged Release Tablets 37.5 mg

PAROXTIME CR 37.5 contains Paroxetine Hydrochloride Prolonged Release Tablets 37.5 mg. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that works by increasing the availability of serotonin, a chemical messenger involved in mood and emotional regulation. The prolonged-release formulation is designed to release the medicine gradually. Paroxetine prolonged-release products are prescription medicines used in adults for certain depressive and anxiety-related disorders.

Because paroxetine affects the central nervous system and can interact with several medicines, PAROXTIME CR 37.5 should be taken only under the supervision of a qualified healthcare professional. It is not intended for self-medication.

Uses

Paroxetine Hydrochloride Prolonged Release Tablets may be prescribed for conditions such as major depressive disorder, panic disorder, social anxiety disorder, and premenstrual dysphoric disorder (PMDD), depending on the prescribed formulation and indication.

Paroxetine may help reduce persistent low mood, loss of interest, excessive worry, panic symptoms, and other emotional symptoms associated with these conditions. It generally takes time to produce its full therapeutic effect, so patients should continue treatment according to their doctor's instructions even if improvement is not immediate.

Benefits

The principal benefit of PAROXTIME CR 37.5 is its SSRI action, which helps regulate serotonin signaling in the brain. By supporting serotonin activity, paroxetine can help improve mood and reduce symptoms associated with depression and certain anxiety disorders.

The prolonged-release form provides a controlled release of the active medicine and is designed for once-daily administration in appropriate patients. This may make the prescribed treatment schedule more convenient. However, the effectiveness of paroxetine varies between individuals, and it should be used as part of a treatment plan developed by a healthcare professional.

Dosage

The dosage of PAROXTIME CR 37.5 must be individualized by a doctor. The appropriate dose depends on the condition being treated, previous response to antidepressant therapy, age, and other medical factors. Official prescribing information for paroxetine controlled-release tablets recommends swallowing the tablet whole rather than chewing or crushing it. Dose adjustments, when required, are generally made gradually.

Do not change the dose, take extra tablets, or stop treatment suddenly. Paroxetine should generally be tapered under medical supervision when discontinuing therapy because abrupt withdrawal can cause discontinuation symptoms. If a dose is missed, follow the instructions provided by your doctor or pharmacist.

Side Effects

Like other antidepressants, Paroxetine Hydrochloride Prolonged Release Tablets can cause side effects. Commonly reported effects include nausea, dizziness, drowsiness, insomnia, dry mouth, constipation, diarrhea, sweating, tremor, decreased appetite, and sexual dysfunction.

Some side effects may improve as the body adjusts to treatment. However, seek urgent medical attention for severe allergic reactions, unusual bleeding, seizures, severe agitation, or symptoms that may indicate serotonin syndrome. Patients and caregivers should also watch for worsening depression, suicidal thoughts, or significant behavioral changes, particularly when starting treatment or changing the dose.

Precautions and Warnings

Before taking PAROXTIME CR 37.5, tell your doctor about any history of bipolar disorder, seizures, glaucoma, liver or kidney problems, bleeding disorders, or other significant medical conditions. Paroxetine can interact with medicines that affect serotonin and should not be combined with certain monoamine oxidase inhibitors (MAOIs). It can also interact with several other medicines, including some drugs metabolized through CYP2D6.

Antidepressants carry an important warning regarding increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults; patients of all ages should be monitored for clinical worsening or unusual behavioral changes.

Pregnant or breastfeeding women should consult their healthcare provider before using paroxetine because treatment may involve potential risks that need individual assessment. Avoid stopping the medicine abruptly, and avoid alcohol or other substances that may increase drowsiness unless your healthcare professional advises otherwise.

Conclusion

PAROXTIME CR 37.5 (Paroxetine Hydrochloride Prolonged Release Tablets 37.5 mg) is an SSRI medicine used under medical supervision for selected depressive and anxiety-related conditions. Its prolonged-release formulation is designed for gradual drug release, while paroxetine's serotonin-related action helps manage symptoms of eligible psychiatric disorders. For safe treatment, use the medicine exactly as prescribed, attend recommended follow-ups, and promptly report serious or concerning symptoms to your healthcare professional.